Currently out of the existing stock ratings of Graham Perry, 8 are a BUY (42.11%), 9 are a HOLD (47.37%), 2 are a SELL (10.53%).

Graham Perry

Work Performance Price Targets & Ratings Chart

Analyst Graham Perry, currently employed at BAML, has had 75% of price targets met with an average potential upside of 49.97%, reached in 2100 days on average.

Graham Perry has documented 29 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on GSK, GlaxoSmithKline PLC ADR at 24-Jul-2026.

Wall Street Analyst Graham Perry

Analyst best performing recommendations are on NVS (NOVARTIS AG ADR).
The best stock recommendation documented was for NVS (NOVARTIS AG ADR) on 10/4/2023. The price target of $118 was fulfilled within 636 days with a profit of $31.31 (36.12%), with a performance score of 0.57.

Average potential price target upside

NVS Novartis AG ADR GSK GlaxoSmithKline PLC ADR SNY Sanofi ADR GILD Gilead Sciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 30-Oct-2026

17 days ago
(30-Oct-2026)

2/2 (100%)

$25.04 (27.08%)

407

Sell Since 10-Sep-2026

$136

$-24.5 (-15.26%)

2 months 6 days ago
(10-Sep-2026)

1/2 (50%)

$-1.48 (-1.08%)

171

Buy Since 26-Mar-2026

$170

$9.5 (5.92%)

$109

7 months 21 days ago
(26-Mar-2026)

6/7 (85.71%)

$20.3 (13.56%)

672

Hold Since 11-Mar-2026

$180

$33.97 (23.26%)

$105

8 months 5 days ago
(11-Mar-2026)

1/2 (50%)

$24.2 (15.53%)

1814

Hold Since 07-Oct-2024

$180

$19.5 (12.15%)

$125

8 months 30 days ago
(17-Feb-2026)

7/8 (87.5%)

$18.74 (11.62%)

1318

Show more analysts

Please expand the browser size to see the chart

Which stock is Graham Perry most bullish on?

Potential upside of $0 has been obtained for GSK (GLAXOSMITHKLINE PLC ADR)

What Year was the first public recommendation made by Graham Perry?

On 2014
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?